139 related articles for article (PubMed ID: 15521928)
1. Developments in treatment of primary irresectable rectal cancer.
Reerink O; Mulder NH; Szabo BG; Sluiter WJ; Wiggers T; Bongaerts AH; Hospers GA
Colorectal Dis; 2004 Nov; 6(6):406-17. PubMed ID: 15521928
[TBL] [Abstract][Full Text] [Related]
2. Prospective assessment of imaging after preoperative chemoradiotherapy for rectal cancer.
Pomerri F; Pucciarelli S; Maretto I; Zandonà M; Del Bianco P; Amadio L; Rugge M; Nitti D; Muzzio PC
Surgery; 2011 Jan; 149(1):56-64. PubMed ID: 20452636
[TBL] [Abstract][Full Text] [Related]
3. Clinical examination following preoperative chemoradiation for rectal cancer is not a reliable surrogate end point.
Guillem JG; Chessin DB; Shia J; Moore HG; Mazumdar M; Bernard B; Paty PB; Saltz L; Minsky BD; Weiser MR; Temple LK; Cohen AM; Wong WD
J Clin Oncol; 2005 May; 23(15):3475-9. PubMed ID: 15908656
[TBL] [Abstract][Full Text] [Related]
4. Pre- and postoperative adjuvant therapy for locally advanced rectal cancer.
McGartland LP; Mulcahy MF; Benson AB
Clin Adv Hematol Oncol; 2004 Dec; 2(12):806-14. PubMed ID: 16166957
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of rectal cancer].
Bülow S; Rasmussen PC; Jakobsen AK
Ugeskr Laeger; 2005 Nov; 167(45):4255-7. PubMed ID: 16277922
[TBL] [Abstract][Full Text] [Related]
6. Optimal staging and treatment of localised rectal cancer.
Påhlman L
Ann Oncol; 2002; 13 Suppl 4():251-5. PubMed ID: 12401698
[No Abstract] [Full Text] [Related]
7. The correlation between tumour regression grade and lymph node status after chemoradiation in rectal cancer.
Berho M; Oviedo M; Stone E; Chen C; Nogueras J; Weiss E; Sands D; Wexner S
Colorectal Dis; 2009 Mar; 11(3):254-8. PubMed ID: 18513188
[TBL] [Abstract][Full Text] [Related]
8. Pseudomyxoma peritonei: review on a cluster of peritoneal mucinous diseases.
Jacquemin G; Laloux P
Acta Chir Belg; 2005 Apr; 105(2):127-33. PubMed ID: 15906901
[TBL] [Abstract][Full Text] [Related]
9. Preoperative local staging of rectal cancer with endorectal MR imaging: comparison with histopathologic findings.
Akin O; Nessar G; Agildere AM; Aydog G
Clin Imaging; 2004; 28(6):432-8. PubMed ID: 15531145
[TBL] [Abstract][Full Text] [Related]
10. Importance of fluorodeoxyglucose-positron emission tomography (FDG-PET) and endoscopic ultrasonography parameters in predicting survival following surgery for esophageal cancer.
Omloo JM; Sloof GW; Boellaard R; Hoekstra OS; Jager PL; van Dullemen HM; Fockens P; Plukker JT; van Lanschot JJ
Endoscopy; 2008 Jun; 40(6):464-71. PubMed ID: 18543134
[TBL] [Abstract][Full Text] [Related]
11. Preoperative chemoradiation therapy for low rectal cancer. Impact on downstaging and sphincter-saving operations.
Habr-Gama A; Perez RO; Kiss DR; Rawet V; Scanavini A; Santinho PM; Nadalin W
Hepatogastroenterology; 2004; 51(60):1703-7. PubMed ID: 15532809
[TBL] [Abstract][Full Text] [Related]
12. Results of laparoscopic anterior resection for rectal adenocarcinoma: retrospective analysis of 157 cases.
Pugliese R; Di Lernia S; Sansonna F; Scandroglio I; Maggioni D; Ferrari GC; Costanzi A; Magistro C; De Carli S
Am J Surg; 2008 Feb; 195(2):233-8. PubMed ID: 18083137
[TBL] [Abstract][Full Text] [Related]
13. [A T3 cancer of the mid-rectum].
Penna Ch
J Chir (Paris); 2002 Sep; 139(4):228-30. PubMed ID: 12410141
[No Abstract] [Full Text] [Related]
14. Lateral pelvic lymph node dissection or chemoradiotherapy: which is the procedure of choice to reduce local recurrence rate in lower rectal cancer?
Watanabe T; Matsuda K; Nozawa K; Kobunai T
Ann Surg; 2008 Aug; 248(2):342-3; author reply 343. PubMed ID: 18650647
[No Abstract] [Full Text] [Related]
15. Rectal cancer.
Zampino MG; Labianca R; Beretta GD; Magni E; Gatta G; Leonardi MC; Chiappa A; Biffi R; de Braud F; Wils J
Crit Rev Oncol Hematol; 2009 May; 70(2):160-82. PubMed ID: 19059790
[TBL] [Abstract][Full Text] [Related]
16. Treatment of locally advanced rectal cancer.
Klaassen RA; Nieuwenhuijzen GA; Martijn H; Rutten HJ; Hospers GA; Wiggers T
Surg Oncol; 2004; 13(2-3):137-47. PubMed ID: 15572096
[TBL] [Abstract][Full Text] [Related]
17. Local staging of rectal cancer: a review of imaging.
Beets-Tan RG; Beets GL
J Magn Reson Imaging; 2011 May; 33(5):1012-9. PubMed ID: 21509856
[TBL] [Abstract][Full Text] [Related]
18. The multidisciplinary rectal cancer treatment: main convergences, controversial aspects and investigational areas which support the need for an European Consensus.
Valentini V; Glimelius B; Minsky BD; Van Cutsem E; Bartelink H; Beets-Tan RG; Gerard JP; Kosmidis P; Pahlman L; Picciocchi A; Quirke P; Tepper J; Tonato M; Van de Velde CJ; Cellini N; Latini P
Radiother Oncol; 2005 Sep; 76(3):241-50. PubMed ID: 16165238
[TBL] [Abstract][Full Text] [Related]
19. Rectal cancer adjuvant therapy controversies: When? What? Why?
Rakinic J; Fry R
Surg Oncol Clin N Am; 2000 Oct; 9(4):801-8; discussion 809-11. PubMed ID: 11008247
[TBL] [Abstract][Full Text] [Related]
20. Preoperative neo-adjuvant therapy for curable rectal cancer--reaching a consensus 2008.
Scott NA; Susnerwala S; Gollins S; Myint AS; Levine E
Colorectal Dis; 2009 Mar; 11(3):245-8. PubMed ID: 18637934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
